Solventum Corporation vs Abbvie Inc.
SOLV vs ABBV — side-by-side comparison from reported financials. SOLV leads 5, ABBV leads 5 of 10 comparable metrics.
Solventum Corporation
SOLV · Healthcare
$87.88+1.70%Strained
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | SOLV | ABBV |
|---|---|---|
| Price | $87.88 | $276.43 |
| Market cap | $15.0B | $488B |
| Revenue (TTM) | $8.31B | $64.4B |
| Revenue growth | +0.8% | +1.8% |
| Net margin | 17.3% | 9.8% |
| Free cash flow | -$118M | $18.2B |
| Net cash (debt) | ($4.16B) | ($56.2B) |
| 1-year price return | +22.4% | +19.8% |
| P/E | 10.4 | 77.4 |
| P/E vs own history (cheap-side %) | 66% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | 29% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 6 of 10 | 9 of 10 |
| Employees | 20,000 | 57,000 |
Full résumé-style profiles: SOLV CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.